Vaxiion Therapeutics, LLC
San Diego, CA
- UEI
- FU87Q5D52MK5
- CAGE
- 47N62
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 11585 Sorrento Valley Rd #105, San Diego, CA 92121, USA
- Website
- vaxiion.com
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- Cloud Services
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Preclinical development of VAX024 - a novel targeted combination sting agonist/oncolytic agent - project summary vaxiion… | National Cancer Institute | $306,265 | |
| Preclinical evaluation of VAX014 in combination with immune checkpoint inhibitors | National Cancer Institute | $232,276 | |
| Immunotherapeutic minicells for use in intermediate and high-risk non-muscle inva | National Institutes of Health | $213,828 | |
| Scaling up bacterial minicell production | National Institutes of Health | $130,000 |
Quick answers
What is Vaxiion Therapeutics, LLC's UEI?
Vaxiion Therapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is FU87Q5D52MK5.
What is Vaxiion Therapeutics, LLC's CAGE code?
Vaxiion Therapeutics, LLC's CAGE code is 47N62.
What is Vaxiion Therapeutics, LLC's primary NAICS code?
Vaxiion Therapeutics, LLC's primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Vaxiion Therapeutics, LLC located?
Vaxiion Therapeutics, LLC's physical address in SAM.gov is 11585 Sorrento Valley Rd #105, San Diego, CA 92121, USA.
Is Vaxiion Therapeutics, LLC registered in SAM.gov?
Yes. Vaxiion Therapeutics, LLC's SAM.gov registration is active through February 5, 2027.
What is Vaxiion Therapeutics, LLC's most recent federal award?
Vaxiion Therapeutics, LLC's most recent federal grant award is Preclinical development of VAX024 - a novel targeted combination sting agonist/oncolytic agent - project summary vaxiion… (R43CA298595), from National Cancer Institute, on September 16, 2025.
On GovTribe
See Vaxiion Therapeutics, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors